Ligand validation:3ACS

BGC: beta-D-glucopyranose

BGC is a Ligand Of Interest in 3ACS designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3ACS_BGC_B_2901	75%	47%	0.129	0.961	0.58	1.44	-	1	0	0	100%	1
3ACS_BGC_A_1901	72%	57%	0.141	0.966	0.54	1.09	-	2	0	0	100%	1
3ACT_BGC_B_3901	99%	47%	0.05	0.988	0.92	1.12	-	1	0	0	100%	1
3AFJ_BGC_A_2901	99%	59%	0.054	0.989	0.59	0.96	-	1	0	0	100%	1
3QFZ_BGC_B_2901	93%	38%	0.095	0.99	0.81	1.58	-	4	0	0	100%	1
3QFY_BGC_A_1901	87%	46%	0.115	0.988	0.84	1.25	-	1	0	0	100%	1
3QG0_BGC_A_1901	78%	50%	0.134	0.976	0.45	1.47	-	1	0	0	100%	1
1HHU_BGC_C_8	100%	67%	0.037	0.997	0.6	0.68	-	-	0	0	100%	0.9167
4IIG_BGC_B_950	100%	50%	0.035	0.987	0.78	1.13	-	2	1	0	100%	1
2V3G_BGC_A_1281	100%	68%	0.051	0.994	0.52	0.69	-	-	0	0	100%	1
5DNF_BGC_A_102	100%	26%	0.047	0.988	2.1	0.95	3	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.